University of Virginia scientists have developed three artificial intelligence-powered tools aimed at speeding up new medicine creation. The suite addresses common hurdles in pharmaceutical research by accounting for protein flexibility during drug design. Researchers say these freely available resources could help lower costs and improve success rates.
